ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2579 • 2015 ACR/ARHP Annual Meeting

    Effect of Tacrolimus on Endoplasmic Reticulum Stress-Mediated Osteoclastogenesis in a Collagen-Induced Arthritis Mouse Model

    Won-Seok Lee1, Yun Jung Choi2, Myong-Joo Hong3, Chang-Hoon Lee4,5, Myeung Su Lee6, Young Sun Suh7, Sang-Il Lee8 and Wan-Hee Yoo9, 1Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University Hospital-Chonbuk National University, jeonju, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University Hospital-Chonbuk National University, JeonJu, South Korea, 3Internal Medicine, Presbyterian Medical center, Jeonju, South Korea, 4Department of Internal Medicine, School of Medicine, Wonkwang University, Iksan, Chonbuk, South Korea, 5Rheumatology, Department of Internal Medicine, School of medicine, Wonkwang university, Iksan, Chonbuk, South Korea, 6Internal Medicine, School of Medicine, Wonkwang University, Iksan, Chonbuk, South Korea, 7Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea, 8Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 9Division of Rhuematology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University Hospital-Chonbuk National University, Jeonju, South Korea

    Background/Purpose: Although the effects of tacrolimus on T cells are well known, its direct effects on osteoclastogenesis remain unclear. We previously revealed that thapsigargin (TG)-induced…
  • Abstract Number: 2580 • 2015 ACR/ARHP Annual Meeting

    Age-Related Differences in Collagen-Induced Arthritis: Clinical, Imaging and Biological Characteristics in Juvenile Compared to Adult Animals

    Tracy Wilson-Gerwing1, Arash Panahifar2, David M.L. Cooper2 and Alan M. Rosenberg1, 1Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada, 2Anatomy and Cell Biology, University of Saskatchewan, Saskatoon, SK, Canada

    Background/Purpose: Arthritis is among the most common chronic diseases in both children and adults. Joint inflammation is a feature in both age groups but there…
  • Abstract Number: 2581 • 2015 ACR/ARHP Annual Meeting

    TNF-Alpha Receptor II Signaling Plays an Important Role in Maintaining the Expression of Forkhead Box P3 in Murine Regulatory T Cells

    Wen-Yi Tseng1,2, Kay McNamee1, Adam Cribbs3, Anviti Vyas1 and Richard O. Williams1, 1Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom, 2Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan, 3Computational Genomics and Training Centre, MRC Functional Genomics Unit, University of Oxford, Oxford, United Kingdom

    Background/Purpose: TNF-α is a key regulator of inflammation, which induces signal transduction by binding to two structurally and functionally distinct receptors on target cells: TNF…
  • Abstract Number: 2582 • 2015 ACR/ARHP Annual Meeting

    Increased Morbidity and Mortality in Female Versus Male Tumor Necrosis Factor-Transgenic Mice

    Richard Bell1, Ronald Wood2, Joe Chakkalakal3, Christopher T. Ritchlin4, Edward Schwarz5 and Homaira Rahimi6, 1Pathology, University of Rochester, Rochester, NY, 2University of Rochester, Rochester, NY, 3Orthopaedics, University of Rochester, Rochester, NY, 4Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 5Orthopedeatrics, University of Rochester, Rochester, NY, 6Rheumatology, University of Rochester/Golisano Children's Hosp, Rochester, NY

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic debilitating condition with a 2-3 fold greater prevalence in women than men. Additionally, women have worse disease outcomes…
  • Abstract Number: 2583 • 2015 ACR/ARHP Annual Meeting

    Important Role of CD11c+ Dendritic Cells in Inflammatory Arthritis

    Antonia Puchner1, Victoria Saferding2, Eliana Goncalves-Alves3, Gerhard Krönke4, Rene Pfeifle4, Silvia Hayer5, Josef S. Smolen6, Kurt Redlich3,7 and Stephan Blüml3, 1Department of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Rheumatology, Medical University of Vienna, Vienna, Austria, 3Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 4Universitätsklinikum Erlangen, Erlangen, Austria, 5Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 6Department of Medicine 3, Division of Rheumatology, Medical University Vienna, Vienna, Austria, 7Medical University Vienna, Dpt. of Rheumatology, Vienna, Austria

    Background/Purpose: Dendritic cells (DCs) play an important role in bridging the innate and the adaptive immune response by serving as antigen presenting cells and are…
  • Abstract Number: 2584 • 2015 ACR/ARHP Annual Meeting

    Prediction of Disease Relapses By Multi-Biomarker Disease Test Activity in Rheumatoid Arthritis Patients Tapering DMARD Treatment

    Juergen Rech1, Axel J. Hueber2, Matthias Englbrecht2, Stephanie Finzel3, Judith Haschka4,5, Bernhard Manger2, Arnd Kleyer3, Michaela Reiser3, Hans-Peter Tony6, Stefan Kleinert7, Martin Feuchtenberger8, Martin Fleck9, Karin Manger10, Wolfgang Ochs11, Matthias Schmitt-Haendle12, Joerg Wendler13, Florian Schuch13, Monika Ronneberger13, Hanns-Martin Lorenz14, Hubert Nüßlein15, Rieke Alten16, Jayme Fogagnolo Cobra17, Joerg C. Henes18, Klaus Krüger19 and Georg A. Schett20, 1medical clinic 3, University of Erlangen-Nuremberg, Erlangen, Germany, 2Department of Internal Medicine 3, Rheumatology & Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 3Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 4Medical Department 3, Rheumatology & Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 5Medical Department II, Medical University of Vienna, St. Vincent Hospital Vienna,, Vienna, Austria, 6University Hospital Würzburg, Würzburg, Germany, 7Rheumatologische Schwerpunktpraxis Erlangen, Erlangen, Germany, 8Rheumatologie/Klinische Immunologie, Kreiskliniken Altötting-Burghausen, Burghausen, Germany, 9Department of Internal Medicine I, University of Regensburg, 93042 Regensburg, Germany, 10Rheumatology Practice Bamberg, Bamberg, Germany, 11Rheumatologist in Private Practice, Bayreuth, Germany, 12Rheumatology Practice, Bayreuth, Germany, 13Schwerpunktpraxis Rheumatologie, Erlangen, Germany, 14University Hospital Heidelberg, Heidelberg, Germany, 15University Erlangen, Nürnberg, Germany, 16Internal Medicine, Rheumatology & Clinical Immunology, Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany, 17Instituto de Reumatologia de Sao Paolo, Sao Paolo, Brazil, 18Department of Internal Medicine II, Rheumatology Division, University Hospital Tuebingen, Tuebingen, Germany, 19Praxiszentrum St. Bonifatius, München, Germany, 20University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose: To analyze the role of multi-biomarker disease activity (MBDA) in predicting disease relapses in rheumatoid arthritis (RA) patients in sustained remission, tapering disease modifying…
  • Abstract Number: 2585 • 2015 ACR/ARHP Annual Meeting

    Serum 14-3-3η Is an RA Specific Mechanistic Marker

    Bidisha Dasgupta1, Yauheniya Cherkas1, Sarah Lamberth1, Karen Hayden1, Carrie Brodmerkel1, Anthony Marotta2 and Mark Curran1, 1Janssen Research & Development, LLC., Spring House, PA, 2Augurex Life Sciences Corp., Vancouver, BC, Canada

    Background/Purpose: 14-3-3η is an emerging soluble Rheumatoid Arthritis (RA) biomarker that activates intracellular pathways that lead to the upregulation of inflammatory and joint damage factors.…
  • Abstract Number: 2586 • 2015 ACR/ARHP Annual Meeting

    Cardiac Magnetic Resonance Imaging Reveals Myocardial Damage in Patients with Active Rheumatoid Arthritis

    Miia Holmström1, Riitta Koivuniemi2, Tarja Tiippana-Kinnunen2, Antti Kuuliala3, Marjatta Leirisalo-Repo2 and Sari Kivistö1, 1Radiology, HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 2Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 3Bacteriology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

    Background/Purpose: In rheumatoid arthritis (RA), cardiac involvement is common and frequently subclinical. We used cardiac MRI to identify myocardial abnormalities in patients with active RA,…
  • Abstract Number: 2587 • 2015 ACR/ARHP Annual Meeting

    CRP and 14-3-3η Are Each Associated with Joint Damage Progression, Their Titres Do Not Correlate and Are Better Predictors of Progression Together Than Alone

    Gilles Boire1,2, Nathalie Carrier3, Artur de Brum-Fernandes1,4, Patrick Liang1,4, Ariel Masetto2,5, Yuan Gui6, Jane Savill6, Sara Michienzi6, Henri Ménard7, Walter Maksymowych8 and Anthony Marotta6, 1Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada, 2Department of Medicine/Division of Rheumatology, University of Sherbrooke, Sherbrooke, QC, Canada, 3Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 5Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada, 6Augurex Life Sciences Corp., Vancouver, BC, Canada, 7MSK Research Axis, McGill University Health Center Research Institute, Montreal, QC, Canada, 8Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: As a marker of inflammation and an acute phase reactant, C-reactive protein (CRP) is routinely used in clinical practice and in RA classification criteria.…
  • Abstract Number: 2588 • 2015 ACR/ARHP Annual Meeting

    Survivin Links Smoking and High Prevalence of Rheumatoid Arthritis in Women

    Minna Turkkila1, Apostolos Bossios2, Malin Erlandsson3, Karin ME Andersson3, Sofia Töyrä Silfverswärd4, Maria Rolf5, Linda Ekerljung2, Carina Malmhäll2, Bo Lundbäck2 and Maria Bokarewa6, 1University of Göteborg, Göteborg, Sweden, 2The Krefting Research Centre, University of Gothenburg, Gothenburg, Sweden, 3Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden, 4Department of Rheumatology and Inflammation Research, Gothenburg University, Gothenburg, Sweden, 5Department of Rheumatology and Inflammation Research University of Gothenburg, Gothenburg, Sweden, 6Rheumatology and Inflammation Research, Göteborgs University, Göteborg, Sweden

    Background/Purpose : Patients with rheumatoid arthritis (RA) are predominantly female, smokers and positive for autoantibodies, rheumatoid factor and antibodies to citrullinated peptides. The oncoprotein survivin…
  • Abstract Number: 2589 • 2015 ACR/ARHP Annual Meeting

    Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis

    Christian G. Ammitzbøll1, Rudi Steffensen2, Martin Bøgsted3,4, Kaspar Rene Nielsen2, Torkell Ellingsen5, Merete Lund Hetland6, Peter Junker5, Jan Pødenphant7, Mikkel Østergaard8, Julia Johansen9, Kim Hørslev-Petersen10 and Kristian Stengaard-Pedersen1, 1Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 2Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark, 3Department of Haematology, Aalborg University Hospital, Aalborg, Denmark, 4Department of Mathematical Sciences, Aalborg University, Aalborg, Denmark, Aalborg, Denmark, 5Department of Rheumatology, Odense University Hospital, Odense, Denmark, 6DANBIO, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Glostrup, Denmark, 7Department of Rheumatology, Copenhagen University Hospital at Gentofte, Glostrup, Denmark, 8Rigshospitalet-Glostrup, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, Glostrup, Denmark, 9Departments of Medicine and Oncology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark, 10Rheumatology, Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Graasten, Denmark

    Background/Purpose: Genome-wide association studies (GWAS) and meta-GWAS studies have identified >50 single nucleotide-polymorphisms (SNPs) that are associated with susceptibility to rheumatoid arthritis (RA). It is,…
  • Abstract Number: 2590 • 2015 ACR/ARHP Annual Meeting

    Anti-Citrullinated Protein Antibody and Radiographic Disease Progression in Rheumatoid Arthritis

    Brian Coburn1, Geoffrey M. Thiele1, Michael J. Duryee2, Fang Yu3, Harlan Sayles4, Jeremy Sokolove5, WH Robinson6, Alan Erickson7, Mary Brophy8, James R. O'Dell1 and Ted R. Mikuls1, 1Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 2Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 3Public Health, University of Nebraska Medical Center, Omaha, NE, 4University of Nebraska Medical Center, Omaha, NE, 5Stanford University, Palo Alto, CA, 6VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 7University of Nebraska College of Medicine and VA Nebraska Western Iowa Health Care System, Omaha, NE, 8VA Boston Heathcare System, Boston, MA

    Background/Purpose: Anti-citrullinated protein antibody (ACPA) positivity is associated with more rapid radiographic progression in rheumatoid arthritis (RA). A majority of prior studies, however, have assessed…
  • Abstract Number: 2591 • 2015 ACR/ARHP Annual Meeting

    Ultrasound Residual Synovitis Has an Impact on the Time to Relapse in RA Patients Considered in Clinical Remission: A Real Life Study of 211 Patients

    Pascal Zufferey1, Myriam Riek2, Giorgio Tamborrini3, Laure Brulhart4, Martin Toniolo5, Sandra Blumhardt6, Burkhard Moeller7,8 and Hans Ruedi Ziswiler9, 1Rhu /Dal .Chuv, Rheumatology, Lausanne, Switzerland, 2SCQM Registry, Zurich, Switzerland, 3Rheumatologie, Bethesda spital, Basel, Switzerland, 4médecine, hôpital neuchateulois, La chaux de fond, Switzerland, 5Department of Rheumatology, University Hospital of Zurich, Zurich, Switzerland, 6rheumatology, USZ, zurich, Switzerland, 7Rheumatology, Inselspital-University Hospital, Bern, Switzerland, 8Rheumatology, Inselspital University Hospital, Bern, Switzerland, 9Osteorheuma, Bern, Switzerland

    Background/Purpose: Previous publications have suggested that patients in clinical remission with residual ultrasound (US) synovitis flare more often and do not stay in remission as…
  • Abstract Number: 2592 • 2015 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Patients with Many Autoantibodies Have Different Characteristics at Presentation Compared to Patients with Few Autoantibodies

    Veerle F.A.M. Derksen1, Sofia Ajeganova2, Annette H.M. van der Helm- van Mil1, Ingiäld Hafström3, T. W. J. Huizinga1, René E. M. Toes1, Leendert A. Trouw1, Björn Svensson4 and Diane van der Woude1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology unit, Department of Medicine,, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden, 3Unit of Rheumatology, Department of Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden, 4Section of Rheumatology, Institution of Clinical Science, Lund University, Lund, Sweden

    Background/Purpose: Patients with rheumatoid arthritis (RA) are frequently positive for one or several autoantibodies like rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) and anti-carbamylated protein…
  • Abstract Number: 2593 • 2015 ACR/ARHP Annual Meeting

    Relationship Between Index of Activity Speed (Time Up and Go test) and Patient-Reported Outcome in Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function

    Toshihisa Kojima1, Hajime Ishikawa2, Keiichiro Nishida3, Sakae Tanaka4, Nobuhiko Haga5, Jun Hashimoto6, Hisaaki Miyahara7, Yasuo Niki8, Masayo Kojima9 and Naoki Ishiguro10, 1Department of Orthopedic Surgery, Nagoya University Hospital, Nagoya, Japan, 2Orthopedic Surgery, Niigata Rheumatic Center, Niigata, Japan, 3Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama city, Japan, 4Orthopaedic Surgery and Spinal Surgery, The University of Tokyo Hospital, Tokyo, Japan, 5Rehabilitation Medicine, The University of Tokyo Hospital, Tokyo, Japan, 6Dept of Rheumatology, Osaka-Minami Medical Center, Kawachinagano City, Japan, 7Orthopedic Surgery, National Hospital Organization Kyushu Medical Centre, Fukuoka, Japan, 8Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan, 9Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, 10Department of Orthopedic Suregery, Nagoya University Hospital, Nagoya, Japan

    Background/Purpose: Total management including reconstructive joint surgery and rehabilitation should be needed for further improvements of physical function for long-standing RA patients. It is very…
  • « Previous Page
  • 1
  • …
  • 1642
  • 1643
  • 1644
  • 1645
  • 1646
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology